A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants
Clinical trial NCT05662215 · TERMINATED
Trial details
- NCT number
- NCT05662215
- Sponsor
- Cytokinetics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2023-08-08
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.